The document is an intimation of a scheduled Analyst/Investor Meeting to be held on a group basis.
The event is an in-person meeting held as part of the Avendus Spark INDX Annual conference.
The meeting is scheduled for Monday, November 16, 2026, from 12:00 PM to 5:00 PM IST in Mumbai.
The stated purpose of the meeting is for interaction with Analysts and Institutional Investors.
The intimation is made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/ECPH1Q2FY27_f8e43c260a.pdf.
The disclosure and presentation will also be made available on the Company's website at www.starhealth.in.
The notice includes a standard disclaimer that the meeting is subject to changes due to exigencies on the part of the Analysts/Investors.
The document is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer.
Additional Notes Section
The document is a formal regulatory filing submitted to the BSE and NSE.
No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement.
The document does not specify if any unpublished price sensitive information (UPSI) will be shared, nor does it list any management participants.
